Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Immunology Research|May 12, 2015
IL-21: a pleiotropic cytokine with potential applications in oncologyMichela Croce, Valentina Rigo, Silvano FerriniImmunotherapy|March 26, 2015
New immunotherapeutic strategies for the treatment of neuroblastomaMichela Croce, Maria Valeria Corrias, Valentina Rigo, et al.Scientific Reports|October 27, 2017
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastomaValentina Rigo, Laura Emionite, Antonio Daga, et al.Cancer Immunology, Immunotherapy : CII|March 21, 2014
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunityValentina Rigo, Maria Valeria Corrias, Anna Maria Orengo, et al.International Journal of Cancer|December 30, 2009
Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic miceMichela Croce, Maria Valeria Corrias, Anna Maria Orengo, et al.Journal of Immunology Research|May 12, 2015
IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcomeFabio Morandi, Michela Croce, Giuliana Cangemi, et al.Frontiers in Immunology|January 21, 2026
Unveiling the myxofibrosarcoma tumor microenvironment: implications for immunotherapyCecilia Profumo, Massimiliano Grassi, Valentina Rigo, et al.Oncotarget|September 30, 2016
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cellsAndrea Petretto, Grazia Carbotti, Elvira Inglese, et al.Biomed Research International|July 11, 2015
Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall SurvivalSara Stigliani, Michela Croce, Fabio Morandi, et al.International Journal of Molecular Sciences|August 14, 2025
Assessing Determinants of Response to PARP Inhibition in Germline <i>ATM</i> Mutant MelanomaEleonora Allavena, Michela Croce, Bruna Dalmasso, et al.Pageof 2